RA Capital Management »

Sana Biotechnology shares owned by RA Capital Management

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $65M 19M 3.49

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Sana Biotechnology

FMR
Flagship Ventures Management
RA Capital Management
BlackRock
State Street Corporation
Canada Pension Plan Investment Board
Vanguard Capital Management
Bank of America Corporation
Geode Capital Management
Marex Group
Marshall Wace
Alphabet
Goldman Sachs Group
Integral Health Asset Management
Toronto-Dominion Bank

View all funds holding Sana Biotechnology